These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9329313)

  • 1. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Evidence exists from study of non-insulin dependent diabetes in Japan.
    Williams R
    BMJ; 1997 Aug; 315(7107):544. PubMed ID: 9329313
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Factors other than continued use of subcutaneous insulin may be important.
    Fisher BM
    BMJ; 1997 Aug; 315(7107):544. PubMed ID: 9329314
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Intensive insulin regimens in primary prevention should be assessed.
    McLaughlin K
    BMJ; 1997 Aug; 315(7107):544-5. PubMed ID: 9329315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin in the diabetic heart patient, only the glycemic results count].
    Fredenrich A
    Soins; 2006 Mar; (703 Suppl 1):1S18-20. PubMed ID: 16604812
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of diabetic nephropathy--control of blood glucose].
    Nishishita S; Shikata K; Makino H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():384-8. PubMed ID: 15999739
    [No Abstract]   [Full Text] [Related]  

  • 6. The benefits of insulin therapy following acute myocardial infarction revisited.
    Soran H; Barzangy B; Younis N
    QJM; 2006 Sep; 99(9):635-7. PubMed ID: 16921196
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 30 things you should know about managing diabetes.
    Bunker K
    Diabetes Forecast; 2008 Apr; 61(4):54-6. PubMed ID: 18478645
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
    Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
    Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
    Leschke M
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive insulin treatment of diabetic patients with myocardial infarction is highly cost-effective.
    Hildebrandt P
    Eur Heart J; 2000 May; 21(9):700-2. PubMed ID: 10739721
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes control and complications. Where do we go from here?
    Ratner RE
    Online J Curr Clin Trials; 1993 Jun; Doc No 68():[996 words; 6 paragraphs]. PubMed ID: 8313018
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
    Chaturvedi N; Bilous R; Sjolie AK; Klein R;
    Contemp Clin Trials; 2007 Nov; 28(6):780. PubMed ID: 17643353
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes complications. Proactive care a must.
    Mayo Clin Health Lett; 2012 Oct; 30(10):4-5. PubMed ID: 23133856
    [No Abstract]   [Full Text] [Related]  

  • 20. From the control tower: some is better than none and a little bit goes a long way.
    Geffner ME
    J Pediatr; 2001 Dec; 139(6):766-8. PubMed ID: 11743498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.